Bio News. Sunday March 24, 2013 3SBio Inc. Ann

Bio News.

Sunday March 24, 2013

• 3SBio Inc. Announces Extraordinary General Meeting of Shareholders
  10:10 am - PR Newswire


• Veterinary Hospital in Portsmouth Makes Pet Wellness More Affordable
  10:00 am - GlobeNewswire


• Baltimore Pet Care Team Recommends Annual Veterinary Dental Cleanings
  10:00 am - GlobeNewswire


• Evogene Reports Fourth Quarter and Year End 2012 Financial Results
  9:00 am - Marketwire


• "Fountain of Youth" Pill SeroVital™-hgh Huge Draw at D.C. Women's Health Conference
  3:09 am - PR Newswire

Saturday March 23, 2013

• Fortune Magazine Profiles ArcView Group, Co-founded by Steve DeAngelo
  1:33 pm - PR Newswire


• Becker's Spine Review Releases List of 50 Spine Surgeons & Specialists Researching Biologics for Spine Treatments
  2:00 am - PR Newswire

Friday March 22, 2013

• FDA approves Novartis TOBI® Podhaler™ for certain cystic fibrosis patients, the first and only dry powder inhaled antibacterial in US
  8:54 pm - PR Newswire


• CORRECTING and REPLACING FDA Approves GE Healthcare's AdreView™ (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients
  7:07 pm - Business Wire


• Hologic Announces Expiration of 6.25% Senior Notes Exchange Offer
  5:59 pm - PR Newswire


• Bio-pharma Internal Communications Groups Evolving for Structure Optimization
  5:30 pm - PR Newswire


• Research and Markets: Urinary Incontinence - Pipeline Review, H1 2013
  4:58 pm - Business Wire


• Research and Markets: Astrocytoma - Pipeline Review, H1 2013
  4:53 pm - Business Wire


• Research and Markets: 2013 US Respiratory Diseases: Market Outlook and Emerging Opportunities
  4:46 pm - Business Wire


• Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
  4:31 pm - PR Newswire


• Idenix Pharmaceuticals Announces Decision by the United States Patent and Trademark Office Patent Trial and Appeal Board in the First Phase of the Interference
  4:12 pm - GlobeNewswire


• Research and Markets: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2013
  4:12 pm - Business Wire


• Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
  4:08 pm - CNW Group


• Bausch + Lomb Files Registration Statement For Proposed Initial Public Offering
  4:07 pm - PR Newswire


• Accellent Inc. Announces Timing of Fourth Quarter 2012 Earnings Release and Conference Call
  4:05 pm - Business Wire


• Hologic Completes Sale of LIFECODES to Immucor
  4:01 pm - PR Newswire


• The Cooper Companies Holds Annual Meeting of Stockholders
  4:01 pm - GlobeNewswire


• IBEX Announces Departure of its Director of Finance
  4:00 pm - Marketwire


• Walgreens Debuts New Flagship Store in the Iconic Empire State Building
  4:00 pm - Business Wire


• IBEX Announces Departure of its Director of Finance
  4:00 pm - Marketwire